LSL Stock Overview
Develops, manufactures, and commercializes sterile pharmaceutical and natural health products in Canada. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
LSL Pharma Group Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.45 |
| 52 Week High | CA$0.55 |
| 52 Week Low | CA$0.35 |
| Beta | 0 |
| 11 Month Change | 11.11% |
| 3 Month Change | -9.09% |
| 1 Year Change | 12.50% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -40.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| LSL | CA Personal Products | CA Market | |
|---|---|---|---|
| 7D | -4.3% | -1.2% | 0.2% |
| 1Y | 12.5% | 4.5% | 21.0% |
Return vs Industry: LSL exceeded the Canadian Personal Products industry which returned 6.2% over the past year.
Return vs Market: LSL underperformed the Canadian Market which returned 20.2% over the past year.
Price Volatility
| LSL volatility | |
|---|---|
| LSL Average Weekly Movement | 8.8% |
| Personal Products Industry Average Movement | 8.8% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CA Market | 17.5% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: LSL has not had significant price volatility in the past 3 months compared to the Canadian market.
Volatility Over Time: LSL's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 102 | Francois Roberge | www.groupelslpharma.com |
LSL Pharma Group Inc. develops, manufactures, and commercializes sterile pharmaceutical and natural health products in Canada. It offers dietary supplements and vitamins in the tablet and capsule form; and niche sterile ophthalmic products in the form of ointments and drops for pharmacy banners and hospitals. The company is headquartered in Boucherville, Canada.
LSL Pharma Group Inc. Fundamentals Summary
| LSL fundamental statistics | |
|---|---|
| Market cap | CA$51.99m |
| Earnings (TTM) | -CA$2.83m |
| Revenue (TTM) | CA$14.32m |
3.6x
P/S Ratio-18.4x
P/E RatioIs LSL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LSL income statement (TTM) | |
|---|---|
| Revenue | CA$14.32m |
| Cost of Revenue | CA$11.08m |
| Gross Profit | CA$3.25m |
| Other Expenses | CA$6.08m |
| Earnings | -CA$2.83m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.024 |
| Gross Margin | 22.68% |
| Net Profit Margin | -19.74% |
| Debt/Equity Ratio | 57.4% |
How did LSL perform over the long term?
See historical performance and comparison